
This article contains online-exclusive supplemental material for Malik's article entitled, "Allogenic Versus Autologous Stem-Cell Therapy."

This article contains online-exclusive supplemental material for Malik's article entitled, "Allogenic Versus Autologous Stem-Cell Therapy."

The author discusses potential manufacturing costs & challenges of allogeneic & autologous stem-cell therapy.

Eighty drugs will lose patent protection between 2007 and 2011.

Published: July 1st 2012 | Updated:

Published: July 1st 2012 | Updated:

Published: December 1st 2007 | Updated: